Join
Live feed
·
NEWSReleasevia Quantisnow
AbCellera Biologics Inc. logo
Biogen Inc. logo

AbCellera To Collaborate With Biogen To Discover Therapeutic Antibodies For Neurological Conditions

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABCL (AbCellera Biologics Inc.), BIIB (Biogen Inc.) and more on Quantisnow.